|
1
|
Ezzedine K, Eleftheriadou V, Whitton M and
van Geel N: Vitiligo. Lancet. 386:74–84. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ezzedine K, Lim HW, Suzuki T, Katayama I,
Hamzavi I, Lan CC, Goh BK, Anbar T, Silva de Castro C, Lee AY, et
al: Revised classification/nomenclature of vitiligo and related
issues: The Vitiligo Global Issues Consensus Conference. Pigment
Cell Melanoma Res. 25:E1–E13. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gawkrodger DJ, Ormerod AD, Shaw L,
Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J and Young
K: Therapy Guidelines and Audit Subcommittee, British Association
of Dermatologists. et al Guideline for the diagnosis and management
of vitiligo. Br J Dermatol. 159:1051–1076. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Speeckaert R and van Geel N: Vitiligo: An
update on pathophysiology and treatment options. Am J Clin
Dermatol. 18:733–744. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Schwarz DS and Blower MD: The endoplasmic
reticulum: Structure, function and response to cellular signaling.
Cell Mol Life Sci. 73:79–94. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tabas I: Consequences of cellular
cholesterol accumulation: Basic concepts and physiological
implications. J Clin Invest. 110:905–911. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gunia-Krzyżak A, Popiol J and Marona H:
Melanogenesis inhibitors: Strategies for searching for and
evaluation of active compounds. Curr Med Chem. 23:3548–3574.
2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Le Poole IC, Sarangarajan R, Zhao Y,
Stennett LS, Brown TL, Sheth P, Miki T and Boissy RE: ‘VIT1ʼ, A
novel gene associated with vitiligo. Pigment Cell Res. 14:475–484.
2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Huang H, Chen T, Zhou Y, Geng L, Shen T,
Zhou L and Zheng S: RIPK1 inhibition enhances pirarubicin cytotoxic
efficacy through AKT-P21-dependent pathway in hepatocellular
carcinoma. Int J Med Sci. 15:1648–1657. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Linkermann A and Green DR: Necroptosis. N
Engl J Med. 370:455–465. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Galluzzi L, Kepp O, Chan FK and Kroemer G:
Necroptosis: Mechanisms and relevance to disease. Annu Rev Pathol.
12:103–130. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Schneider AT, Gautheron J, Feoktistova M,
Roderburg C, Loosen SH, Roy S, Benz F, Schemmer P, Büchler MW,
Nachbur U, et al: RIPK1 suppresses a TRAF2-dependent pathway to
liver cancer. Cancer Cell. 31:94–109. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Saeed WK and Jun DW: Necroptosis: An
emerging type of cell death in liver diseases. World J
Gastroenterol. 20:12526–12532. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shan B, Pan H, Najafov A and Yuan J:
Necroptosis in development and diseases. Genes Dev. 32:327–340.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cao C and Wan Y: Parameters of protection
against ultraviolet radiation-induced skin cell damage. J Cell
Physiol. 220:277–284. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cao C, Huang X, Han Y, Wan Y, Birnbaumer
L, Feng GS, Marshall J, Jiang M and Chu WM: Galpha(i1) and
Galpha(i3) are required for epidermal growth factor-mediated
activation of the Akt-mTORC1 pathway. Sci Signal.
2(ra17)2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cao C, Lu S, Jiang Q, Wang WJ, Song X,
Kivlin R, Wallin B, Bagdasarian A, Tamakloe T, Chu WM, et al: EGFR
activation confers protections against UV-induced apoptosis in
cultured mouse skin dendritic cells. Cell Signal. 20:1830–1838.
2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cheng LB, Cheng L, Bi HE, Zhang ZQ, Yao J,
Zhou XZ and Jiang Q: Alpha-melanocyte stimulating hormone protects
retinal pigment epithelium cells from oxidative stress through
activation of melanocortin 1 receptor-Akt-mTOR signaling. Biochem
Biophys Res Commun. 443:447–452. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kadekaro AL, Kavanagh R, Kanto H, Terzieva
S, Hauser J, Kobayashi N, Schwemberger S, Cornelius J, Babcock G,
Shertzer HG, et al: Alpha-Melanocortin and endothelin-1 activate
antiapoptotic pathways and reduce DNA damage in human melanocytes.
Cancer Res. 65:4292–4299. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wan J, Lin F, Zhang W, Xu A, DeGiorgis J,
Lu H and Wan Y: Novel approaches to vitiligo treatment via
modulation of mTOR and NF-κB pathways in human skin melanocytes.
Int J Biol Sci. 13:391–400. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Luan Q, Jin L, Jiang CC, Tay KH, Lai F,
Liu XY, Liu YL, Guo ST, Li CY, Yan XG, et al: RIPK1 regulates
survival of human melanoma cells upon endoplasmic reticulum stress
through autophagy. Autophagy. 11:975–994. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Le Poole IC, Das PK, van den Wijngaard RM,
Bos JD and Westerhof W: Review of the etiopathomechanism of
vitiligo: A convergence theory. Exp Dermatol. 2:145–153.
1993.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Speeckaert R and van Geel N: Vitiligo: An
update on pathophysiology and treatment options. Am J Clin
Dermatol. 18:733–744. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gawkrodger DJ, Ormerod AD, Shaw L,
Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J and Young
K: Vitiligo: Concise evidence based guidelines on diagnosis and
management. Postgrad Med J. 86:466–471. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gianfaldoni S, Wollina U, Tirant M,
Tchernev G, Lotti J, Satolli F, Rovesti M, França K and Lotti T:
Herbal compounds for the treatment of vitiligo: A review. Open
Access Maced J Med Sci. 6:203–207. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lotti T, Wollina U, Tchernev G, Valle Y,
Lotti J, França K, Satolli F, Rovesti M, Tirant M, Lozev I, et al:
An innovative therapeutic protocol for vitiligo: Experience with
the Use of Fraxel Herbium laser, topical latanoprost and successive
irradiation with UVA-1 laser. Open Access Maced J Med Sci. 6:49–51.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang M and Kaufman RJ: Protein misfolding
in the endoplasmic reticulum as a conduit to human disease. Nature.
529:326–335. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bu Y and Diehl JA: PERK integrates
oncogenic signaling and cell survival during cancer development. J
Cell Physiol. 231:2088–2096. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ivanova EA and Orekhov AN: The role of
endoplasmic reticulum stress and unfolded protein response in
atherosclerosis. Int J Mol Sci. 17(pii: E193)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Keestra-Gounder AM, Byndloss MX, Seyffert
N, Young BM, Chávez-Arroyo A, Tsai AY, Cevallos SA, Winter MG, Pham
OH, Tiffany CR, et al: NOD1 and NOD2 signalling links ER stress
with inflammation. Nature. 532:394–397. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Schonthal AH: Pharmacological targeting of
endoplasmic reticulum stress signaling in cancer. Biochem
Pharmacol. 85:653–666. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Maurel M, McGrath EP, Mnich K, Healy S,
Chevet E and Samali A: Controlling the unfolded protein
response-mediated life and death decisions in cancer. Semin Cancer
Biol. 33:57–66. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Schonthal AH: Endoplasmic reticulum
stress: Its role in disease and novel prospects for therapy.
Scientifca (Cairo). 2012(857516)2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Pereira DM, Valentão P, Correia-da-Silva
G, Teixeira N and Andrade PB: Translating endoplasmic reticulum
biology into the clinic: A role for ER-targeted natural products?
Nat Prod Rep. 32:705–722. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Park K, Lee SE, Shin KO and Uchida Y:
Insights into the role of endoplasmic reticulum stress in skin
function and associated diseases. FEBS J. 286:413–425.
2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Manga P, Elbuluk N and Orlow SJ: Recent
advances in understanding vitiligo. F1000Res. 5:pii: F1000 Faculty
Rev-2234. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Guan C, Xu W, Hong W, Zhou M, Lin F, Fu L,
Liu D and Xu A: Quercetin attenuates the effects of H2O2 on
endoplasmic reticulum morphology and tyrosinase export from the
endoplasmic reticulum in melanocytes. Mol Med Rep. 11:4285–4290.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Pasparakis M and Vandenabeele P:
Necroptosis and its role in inflammation. Nature. 517:311–320.
2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Silke J, Rickard JA and Gerlic M: The
diverse role of RIP kinases in necroptosis and inflammation. Nat
Immunol. 16:689–697. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
42
|
Amin P, Florez M, Najafov A, Pan H, Geng
J, Ofengeim D, Dziedzic SA, Wang H, Barrett VJ, Ito Y, et al:
Regulation of a distinct activated RIPK1 intermediate bridging
complex I and complex II in TNFα-mediated apoptosis. Proc Natl Acad
Sci USA. 115:E5944–E5953. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Orozco S, Yatim N, Werner MR, Tran H,
Gunja SY, Tait SW, Albert ML, Green DR and Oberst A: RIPK1 both
positively and negatively regulates RIPK3 oligomerization and
necroptosis. Cell Death Differ. 21:1511–1521. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Rickard JA, O'Donnell JA, Evans JM,
Lalaoui N, Poh AR, Rogers T, Vince JE, Lawlor KE, Ninnis RL,
Anderton H, et al: RIPK1 regulates RIPK3-MLKL-driven systemic
inflammation and emergency hematopoiesis. Cell. 157:1175–1188.
2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tenev T, Bianchi K, Darding M, Broemer M,
Langlais C, Wallberg F, Zachariou A, Lopez J, MacFarlane M, Cain K
and Meier P: The Ripoptosome, a signaling platform that assembles
in response to genotoxic stress and loss of IAPs. Mol Cell.
43:432–448. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Park S, Hatanpaa KJ, Xie Y, Mickey BE,
Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA,
et al: The receptor interacting protein 1 inhibits p53 induction
through NF-kappaB activation and confers a worse prognosis in
glioblastoma. Cancer Res. 69:2809–2816. 2009.PubMed/NCBI View Article : Google Scholar
|
